Jan 15, 2019
HINGHAM, Mass. , Jan. 15, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with several
Jan 15, 2019
HINGHAM, Mass. , Jan. 15, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into a definitive agreement with an institutional
Jan 14, 2019
HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical (NASDAQ: MBOT) announced today that it has validated the operational effectiveness of the Company’s Self-Cleaning Shunt (SCS TM ) in a recent independent in-vitro laboratory study. The Company also shared images of its SCS TM from
Jan 14, 2019
HINGHAM, Mass. , Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent Office that it will grant a patent for Application No. 08738207, which covers the Company’s ViRob™ technology platform.
Jan 07, 2019
Regulatory Pre-Submission of the Self-Cleaning Shunt (SCS™) Remains the Primary Operational Objective HINGHAM, Mass. , Jan. 07, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) announced today anticipated operational and product milestones, including pivotal pre-clinical study and
Oct 01, 2018
HINGHAM, Mass. , Oct. 01, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that Harel Gadot , Chief Executive Officer, President, and
Oct 01, 2018
Larger-Scale Pre-Clinical Trial to Validate Positive Outcome of Initial Study; Company Aims to Initiate Regulatory Submissions in mid-2019 HINGHAM, Mass. , Oct. 01, 2018 (GLOBE NEWSWIRE) -- Following the successful outcome of the initial study, Microbot Medical Inc.
Jun 25, 2018
HINGHAM, Mass. , June 25, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that Intellectual Property India has granted patent No.
Jun 18, 2018
HINGHAM, Mass. , June 18, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that the European Patent Office (EPO) has notified the Company that

Displaying 127 - 135 of 158

Search Investor Relations